Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,351,475
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
42,043,809
-
Shares change
-
+1,146,480
-
Total reported value, excl. options
-
$475,104,000
-
Value change
-
+$9,664,162
-
Number of buys
-
22
-
Number of sells
-
-13
-
Price
-
$11.33
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q4 2021
49 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q4 2021.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,043,809 shares
of 55,351,475 outstanding shares and own 75.96% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (25,902,269 shares), FMR LLC (4,429,681 shares), HarbourVest Partners LLC (2,647,059 shares), Artal Group S.A. (2,273,530 shares), STATE OF WISCONSIN INVESTMENT BOARD (1,857,265 shares), CHI Advisors LLC (1,055,882 shares), BlackRock Inc. (1,031,565 shares), Monashee Investment Management LLC (441,176 shares), PLATINUM INVESTMENT MANAGEMENT LTD (414,513 shares), and SPHERA FUNDS MANAGEMENT LTD. (352,948 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.